BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17949898)

  • 1. Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras.
    Shi M; Zheng Y; Garcia A; Xu L; Foster DA
    Cancer Lett; 2007 Dec; 258(2):268-75. PubMed ID: 17949898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells.
    Garcia A; Zheng Y; Zhao C; Toschi A; Fan J; Shraibman N; Brown HA; Bar-Sagi D; Foster DA; Arbiser JL
    Clin Cancer Res; 2008 Jul; 14(13):4267-74. PubMed ID: 18594009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase D stimulation by receptor tyrosine kinases mediated by protein kinase C and a Ras/Ral signaling cascade.
    Voss M; Weernink PA; Haupenthal S; Möller U; Cool RH; Bauer B; Camonis JH; Jakobs KH; Schmidt M
    J Biol Chem; 1999 Dec; 274(49):34691-8. PubMed ID: 10574935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated phospholipase D activity in H-Ras- but not K-Ras-transformed cells by the synergistic action of RalA and ARF6.
    Xu L; Frankel P; Jackson D; Rotunda T; Boshans RL; D'Souza-Schorey C; Foster DA
    Mol Cell Biol; 2003 Jan; 23(2):645-54. PubMed ID: 12509462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase D and RalA cooperate with the epidermal growth factor receptor to transform 3Y1 rat fibroblasts.
    Lu Z; Hornia A; Joseph T; Sukezane T; Frankel P; Zhong M; Bychenok S; Xu L; Feig LA; Foster DA
    Mol Cell Biol; 2000 Jan; 20(2):462-7. PubMed ID: 10611224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-protein-stimulated phospholipase D activity is inhibited by lethal toxin from Clostridium sordellii in HL-60 cells.
    El Hadj NB; Popoff MR; Marvaud JC; Payrastre B; Boquet P; Geny B
    J Biol Chem; 1999 May; 274(20):14021-31. PubMed ID: 10318815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.
    Oliva JL; Zarich N; Martínez N; Jorge R; Castrillo A; Azañedo M; García-Vargas S; Gutiérrez-Eisman S; Juarranz A; Boscá L; Gutkind JS; Rojas JM
    J Biol Chem; 2004 Aug; 279(32):33480-91. PubMed ID: 15181015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
    Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
    Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of Ral GTPase in v-Src-induced phospholipase D activation.
    Jiang H; Luo JQ; Urano T; Frankel P; Lu Z; Foster DA; Feig LA
    Nature; 1995 Nov; 378(6555):409-12. PubMed ID: 7477381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Ras and Ral in chemotactic migration of skeletal myoblasts.
    Suzuki J; Yamazaki Y; Li G; Kaziro Y; Koide H
    Mol Cell Biol; 2000 Jul; 20(13):4658-65. PubMed ID: 10848592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival.
    Carón RW; Yacoub A; Li M; Zhu X; Mitchell C; Hong Y; Hawkins W; Sasazuki T; Shirasawa S; Kozikowski AP; Dennis PA; Hagan MP; Grant S; Dent P
    Mol Cancer Ther; 2005 Feb; 4(2):257-70. PubMed ID: 15713897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of phosphatidylinositol 3-kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation.
    Murphy GA; Graham SM; Morita S; Reks SE; Rogers-Graham K; Vojtek A; Kelley GG; Der CJ
    J Biol Chem; 2002 Mar; 277(12):9966-75. PubMed ID: 11788587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of phospholipase D by ADP-ribosylation factor in rat submandibular acinar cells.
    Li L; Mellow L; Bhullar RP; Fleming N
    Arch Oral Biol; 1998 Mar; 43(3):211-9. PubMed ID: 9631174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative phospholipase D/mTOR survival signal in human breast cancer cells.
    Chen Y; Rodrik V; Foster DA
    Oncogene; 2005 Jan; 24(4):672-9. PubMed ID: 15580312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C delta is required for survival of cells expressing activated p21RAS.
    Xia S; Forman LW; Faller DV
    J Biol Chem; 2007 May; 282(18):13199-210. PubMed ID: 17350960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
    Kang DW; Park MH; Lee YJ; Kim HS; Lindsley CW; Alex Brown H; Min do S
    Int J Cancer; 2011 Feb; 128(4):805-16. PubMed ID: 20473892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipase D1 mediates bFGF-induced Bcl-2 expression leading to neurite outgrowth in H19-7 cells.
    Yoon SN; Kim KS; Cho JH; Ma W; Choi HJ; Kwon SJ; Han JS
    Biochem J; 2012 Jan; 441(1):407-16. PubMed ID: 21916846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibition of phorbol ester-stimulated phospholipase D by Clostridium sordellii lethal toxin and Clostridium difficile toxin B-1470 in HEK-293 cells. Restoration by Ral GTPases.
    Schmidt M; Voss M; Thiel M; Bauer B; Grannass A; Tapp E; Cool RH; de Gunzburg J; von Eichel-Streiber C; Jakobs KH
    J Biol Chem; 1998 Mar; 273(13):7413-22. PubMed ID: 9516439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of phosphoinositide 3-kinase and endocytosis in nerve growth factor-induced extracellular signal-regulated kinase activation via Ras and Rap1.
    York RD; Molliver DC; Grewal SS; Stenberg PE; McCleskey EW; Stork PJ
    Mol Cell Biol; 2000 Nov; 20(21):8069-83. PubMed ID: 11027277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells.
    Lee TJ; Sartor O; Luftig RB; Koochekpour S
    Mol Cancer; 2004 Nov; 3():31. PubMed ID: 15548330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.